Brought to you by 
Glide Pharmaceutical gets £2.3mm through Series C venture round
18 Sep 2007
Executive Summary
Glide Pharmaceutical Technologies (needle-free drug delivery platforms) has raised £2.3mm ($4.6mm) through the closing of its oversubscribed Series C venture round. Current backers such as Oxford Technology 4 VCT were joined by new investors that included Oxford Capital Partners.
Deal Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Controlled Release
- Macromolecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Glide Pharmaceutical gets £2.3mm through Series C venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice